-+ 0.00%
-+ 0.00%
-+ 0.00%

Damora Therapeutics replaces EY Denmark with EY US as auditor

PUBT·04/20/2026 20:01:06
Listen to the news
Damora Therapeutics replaces EY Denmark with EY US as auditor
  • Damora Therapeutics Audit Committee dismissed EY Godkendt Revisionspartnerselskab as independent registered public accounting firm effective April 17, 2026.
  • Audit reports for fiscal years ended Dec. 31, 2025 and 2024 carried no adverse opinion or disclaimer.
  • 2024 audit report included going-concern explanatory paragraph.
  • Company reported no accounting or auditing disagreements with outgoing auditor during 2025-2024 or interim period through April 17, 2026.
  • Audit Committee engaged Ernst & Young LLP as new independent registered public accounting firm effective April 17, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Damora Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-163909), on April 20, 2026, and is solely responsible for the information contained therein.